Target intelligence / Profile preview

MicroRNA 548f-1 (MIR548F1)

Target
MIR548F1
Molecular classification
microRNA, Non-coding RNA, Regulatory RNA
01

Overview

MicroRNA 548f-1 (MIR548F1) is a non-coding microRNA gene that encodes a short RNA molecule (about 20-24 nucleotides), which post-transcriptionally regulates gene expression by binding to target mRNAs, leading to their degradation or inhibition of translation[2]. MIR548F1 is produced from a primary transcript that is processed by Drosha and Dicer nucleases into its mature form, which is then incorporated into the RNA-induced silencing complex (RISC)[2]. MIR548F1 (including mature forms such as miR-548F-3p and miR-548F-5p) has been implicated in the regulation of pathways involved in cell proliferation, spindle assembly checkpoint signaling, and metabolism, especially in cancer contexts like triple-negative breast cancer and head and neck squamous cell carcinoma[1][5]. It serves as a potential prognostic biomarker and may be considered a prospective target for therapeutic research in oncology[1][5]. Key points: - MIR548F1 is a regulatory RNA, not a typical druggable target like a receptor or enzyme. - It regulates cellular processes by targeting mRNAs, not by serving as a receptor or binding site for small molecules. - No approved drugs directly target MIR548F1; however, its modulation is being studied for its effect on disease pathways and therapeutic response[1][5].

Other names
MIRN548F1MIR548F-1hsa-mir-548f-1MIR548F1
02

Biological functions

Post-transcriptional regulation of gene expressionRegulation of mRNA stabilityInhibition of mRNA translationModulation of cellular processes (such as cell cycle and proliferation, particularly in cancer contexts)
03

Disease associations

Cancer (notably triple-negative breast cancer and head and neck squamous cell carcinoma)Carotid artery dissection (association only)Traumatic glaucoma (association only)Other (potential prognostic biomarker)
04

Biomarkers

Potential prognostic biomarker in triple-negative breast cancer (based on expression level as related to patient survival and cancer aggressiveness)Prognostic marker in head and neck squamous cell carcinoma (HNSCC) (expression related to TP53 gene regulation and patient survival)

Beyond the preview

Go deeper on MicroRNA 548f-1 (MIR548F1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 548f-1 (MIR548F1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call